NCT05255900View on ClinicalTrials.gov

Effects of Metyrapone in Patients With Hypercortisolism

Active, not recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Hypercortisolism
Interventions
DRUG

Metyrapone Capsules

Exposure to 24 weeks of treatment with metyrapone

Trial Locations (1)

20149

Istituto Auxologico Italiano, Milan

Sponsors

Collaborators (1)

HRA Pharma
All Listed Sponsors
collaborator

HRA Pharma

INDUSTRY

lead

Istituto Auxologico Italiano

OTHER

NCT05255900 - Effects of Metyrapone in Patients With Hypercortisolism | Biotech Hunter | Biotech Hunter